Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 9Recruiting 5Withdrawn 2Unknown 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1

Conditions

Neoplasms 1Inflammatory Bowel Diseases 1Dyspnea 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × Oxygen × Clear all
NCT06109961 2023-11-07

HYPNOTIC

Ottawa Hospital Research Institute

Phase 1/2 Unknown
40 enrolled

Inflammatory Bowel Diseases

NCT02357134 2022-12-07

High-Flow Oxygen in Reducing Shortness of Breath Caused by Exercise in Patients With Cancer

M.D. Anderson Cancer Center

Phase 2 Unknown
74 enrolled 16 charts
Other

Dyspnea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡